*Editor*

The coronavirus disease 2019 (COVID‐19) outbreak has had an immeasurable impact on surgical services within the United Kingdom. The disruption to elective surgical procedures has been well‐commented on[^1^](#bjs11984-bib-0001){ref-type="ref"}, but the increased strain on emergency surgical work must also be appreciated. Most hospitals have had to adjust their triage systems, rapidly produce new patient pathways and innovate new infection control measures to ensure emergency operating theatres are clean and accessible[^2^](#bjs11984-bib-0002){ref-type="ref"}. Furthermore, the logistical challenges of COVID‐19 have been accompanied by equally great clinical challenges. The acutely unwell surgical patient must now also face an assessment of their COVID‐19 status; a vital addition to surgical clerking to enable the safe triage and treatment of these patients. Moreover, as many have experienced, an acute surgical admission can in fact be a medical admission in disguise. With that in mind, the COVID‐19 pandemic has provided motivation to more thoroughly investigate all the bodily systems of a patient presenting with a 'surgical abdomen'.

A common presenting complaint referred to the surgical registrar is abdominal pain, focused within the right upper quadrant (RUQ) of the abdomen. Pain in this area is often related to surgical pathology, such as cholecystitis or pancreatitis. The relatively high incidence of these pathologies means that the presence of this pain alone may garner a surgical assessment, and potentially a surgical admission. However, the differential diagnosis of this presenting complaint has classically included that of right lower lobe pneumonia. A diagnosis that is important not to miss, especially in the current COVID‐19 climate.

Research has shown that COVID‐19 can present with acute RUQ abdominal pain with no other typical signs of respiratory infection (fever, oxygen requirement, tachypnoea)[^3^](#bjs11984-bib-0003){ref-type="ref"}. The situation is further complicated by the fact that the COVID‐19 RT‐PCR swab has been shown to have limited diagnostic value in certain cases, or when patients are swabbed with poor technique, due to a relatively high rate of false negatives[^4^](#bjs11984-bib-0004){ref-type="ref"}. Therefore, situations can conceivably occur (and have been seen in practice) in which a patient with COVID‐19 pneumonia is triaged to the surgical ward for further assessment of their RUQ abdominal pain.

In other cases, there may be true surgical pathology and concurrent COVID‐19 infection. Whilst more straight forward than the example previously mentioned if the patient has confirmed infection, difficulty can arise when a patient has a false negative swab[^4^](#bjs11984-bib-0004){ref-type="ref"} or when nosocomial infection has occurred silently. Furthermore, COVID‐19 has added extra significance to the investigation of post‐operative fever[^5^](#bjs11984-bib-0005){ref-type="ref"} as centres battle to reduce transmission within inpatient surgical settings.

The presence of surgical pathology in a patient with acute abdominal pain should not halt further investigation for COVID‐19 infection. The avoidance of this search‐satisfying bias is imperative, as studies have reported silent COVID‐19 infection in surgical patients, as well as COVID‐19 infection being a direct cause of acute abdominal pain[^6^](#bjs11984-bib-0006){ref-type="ref"}.
